Compound Detail
CHEMBL4755731
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
O=C1/C(=C/c2cccc(F)c2)CN(S(=O)(=O)c2ccc(F)cc2)C/C1=C\c1cccc(F)c1
Basic Information
| ChEMBL ID | CHEMBL4755731 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZABFYWRPFPWNDZ-AYKLPDECSA-N |
4
Targets
4
Activities
1
Assay Types
0
PK Parameters
5
Publications
0
Known Names
Molecular Properties
469.5
MW (Da)
4.84
ALogP
3
HBA
0
HBD
54.5
PSA (Ų)
0.51
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 5.3
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HepG2 | IC50 | = | 5000.0 | nM | 5.3 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability i... | 32371335 |
| SMMC-7721 | IC50 | = | 13500.0 | nM | 4.87 | Cytotoxicity against human SMMC-7721 cells assessed as reduction in cell viabili... | 32371335 |
| Unchecked | IC50 | = | 15400.0 | nM | 4.81 | Cytotoxicity against human HHL-5 cells assessed as reduction in cell viability i... | 32371335 |
| L02 | IC50 | = | 21900.0 | nM | 4.66 | Cytotoxicity against human L02 cells assessed as reduction in cell viability inc... | 32371335 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32371335 | 10.1016/j.ejmech.2020.112366 | HepG2 | 1 |
| 32371335 | 10.1016/j.ejmech.2020.112366 | SMMC-7721 | 1 |
| 32371335 | 10.1016/j.ejmech.2020.112366 | Unchecked | 1 |
| 32371335 | 10.1016/j.ejmech.2020.112366 | L02 | 1 |
| 32371335 | 10.1016/j.ejmech.2020.112366 | RAW264.7 | 1 |
Data from ChEMBL 36 via Core Engine